Iterum Therapeutics(ITRM) - 2024 Q2 - Quarterly Results

EXHIBIT 99.1 FOR IMMEDIATE RELEASE Iterum Therapeutics Reports Second Quarter 2024 Financial Results -- FDA PDUFA Action Date of October 25, 2024; Advisory Committee Meeting on September 9, 2024— --Cash Runway into 2025, including through PDUFA Action Date-- --Company to Host Conference Call Today at 8:30 a.m. EDT-- DUBLIN, Ireland and CHICAGO, August 14, 2024 -- Iterum Therapeutics plc (Nasdaq: ITRM), (Iterum) a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibio ...